Last reviewed · How we verify
NCT07028021
Study on Water Turnover of the Chinese Population Based on Deuterium Dilution Method
trial in Water Turnover in 300 participants. Currently enrolling.
30 June 2026
Quick facts
| Lead sponsor | Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 300 |
| Start date | 6 May 2025 |
| Primary completion | 30 June 2026 |
| Estimated completion | 30 October 2026 |
| Sites | 1 location across China |
Conditions studied
- Water Turnover — all drugs for Water Turnover →
- Population Water Requirements — all drugs for Population Water Requirements →
- Deuterium Dilution — all drugs for Deuterium Dilution →
Sponsor
Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences
Who can join
18 and older, any sex, with Water Turnover or Population Water Requirements. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Water is essential for sustaining life and maintaining health. The human body relies on water to transport nutrients and waste products, lubricate joints, regulate body temperature, and preserve tissue structure. International research has shown that losing just 2% of body weight through water loss can impair physiological functions and reduce response capacity. Adequate water intake plays a crucial protective role in health: it helps regulate body weight, lowers the risk of chronic diseases such as cardiovascular and cerebrovascular conditions, and supports cognitive function. However, the common recommendation to drink eight cups of water per day lacks strong scientific evidence. Most national hydration guidelines are based on average population intake, and personalized water intake recommendations have yet to be fully developed. In this study, the investigators will use the deuterium dilution technique to measure water turnover in volunteers. Body composition will be assessed using the TANITA MC-780, while a seven-day fluid intake diary will track daily water consumption. Physical activity levels will be monitored using GT3 devices, and environmental data-including altitude, temperature, and humidity-will be collected based on participants' locations. The goal of this study is to collect comprehensive data on the physiological traits, environmental influences, and hydration needs of the Chinese population. This will allow for refinement and optimization of current prediction equations for water requirements. Ultimately, the investigators aim to develop a new, individualized water intake algorithm tailored to the Chinese population by quantifying the proportion of water intake relative to total water requirements.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07028021
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences trials
Trials by the same sponsor.
- NCT07530939 — The Relationship Between Satiety Per Calorie (SPC) and Food Intake · NA · not yet recruiting
- NCT07371559 — Assessment of Food Intake Using Both 3D Scanning Method and a Photographic Method · recruiting
- NCT07128238 — Research on "Metabolic Adaptation" in Obese People · NA · not yet recruiting
- NCT07054294 — Total Energy Expenditure Across the Life Course in Low-and Middle-Income Countries -- Chinese Children · recruiting
- NCT07056504 — Technologies and Systems for Assessing Human Energy Metabolism and Nutritional Rehabilitation · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07028021 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences
- Last refreshed: 19 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07028021.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing